Understanding Herpes: The Complete HSV Guide for 2026

A comprehensive, medically-informed guide to herpes simplex virus — from types and transmission to testing, treatment, and living well with HSV.

What Is Herpes?

Herpes simplex virus, commonly referred to as herpes, is one of the most widespread viral infections in the world. It belongs to the Herpesviridae family of viruses — a group that also includes varicella-zoster (chickenpox and shingles), Epstein-Barr virus (mono), and cytomegalovirus. There are two primary types of herpes simplex: HSV-1 and HSV-2. Both are lifelong infections, meaning once you contract the virus, it remains in your body permanently. However, the virus spends most of its time dormant, residing in nerve ganglia and causing no symptoms whatsoever.

When herpes is active, it can cause outbreaks — clusters of small blisters or sores that appear on or around the mouth (oral herpes) or the genitals (genital herpes). The first outbreak is usually the most severe, and later outbreaks are usually shorter and milder, according to the World Health Organization. Most people with herpes have no symptoms or only mild ones, and many do not know they have the infection at all.

For most people, the cultural weight placed on herpes far exceeds its medical impact. Herpes is treatable but not curable, and for most people it is a manageable condition of the skin. Serious complications are rare but real: the WHO lists brain infection (encephalitis), eye infection (keratitis) and, in newborns exposed during delivery, neonatal herpes. People with a weakened immune system can have more severe symptoms and more frequent outbreaks, and HSV-2 infection raises the risk of acquiring HIV about three-fold — one more reason to keep up with regular sexual health care. For most people, though, the heaviest burden of herpes is emotional, and much of that weight comes from social stigma rather than from the virus itself.

Understanding the basic biology of herpes is the first step toward demystifying it. The more you know about how the virus works, the less power stigma has over your perception of it. For a broader look at how stigma distorts our understanding of herpes, see our companion guide on herpes stigma.

HSV-1 vs HSV-2: What Is the Difference?

HSV-1 and HSV-2 are two distinct but closely related strains of the herpes simplex virus. Historically, HSV-1 was associated almost exclusively with oral herpes (cold sores) and HSV-2 with genital herpes. However, this neat division has become increasingly blurred. The CDC reports that an increasing proportion of genital herpes is caused by HSV-1, especially among young women and men who have sex with men, usually passed to the genitals through oral sex.

The biological differences between the two are modest. When the HSV-2 genome was sequenced, every HSV-2 gene had an HSV-1 counterpart, and about 83% of the DNA letters in their matching protein-coding regions were identical. Both establish lifelong latency in nerve ganglia, and both can cause sores in the oral or genital region. The key differences lie in their behavioral tendencies: HSV-1 has a strong preference for the oral region, and when it infects the genitals it recurs and sheds much less often than genital HSV-2, according to CDC treatment guidelines.

From a stigma perspective, the distinction between HSV-1 and HSV-2 has created a moral hierarchy that has no medical basis. Society broadly accepts cold sores as normal while treating genital herpes as something shameful — even though the same virus can cause both. This double standard is one of the most irrational aspects of herpes stigma. For a comprehensive comparison of the two types, see our detailed article on HSV-1 vs HSV-2.

Whether you have HSV-1, HSV-2, or both, your experience living with herpes will be shaped far more by your mindset and your support system than by which specific strain you carry. Both types are manageable, both are common, and neither defines your worth.

GHSV-1: Genital HSV-1 Explained

Genital HSV-1, often abbreviated as GHSV-1, is an increasingly common diagnosis that many people and even some healthcare providers do not fully understand. It occurs when HSV-1, the strain traditionally associated with oral cold sores, is transmitted to the genital area — typically through oral sex. HSV-1 is now the leading cause of first-episode genital herpes in many countries.

The clinical course of GHSV-1 tends to be milder than genital HSV-2. A 2022 study in JAMA followed 82 people after a first episode of genital HSV-1. People with a brand-new HSV-1 infection had a median of one genital recurrence in the first year, and people who already had HSV-1 antibodies had a median of zero. Genital shedding was common at first — the virus was found on about 12% of swab days two months after the first episode — but it fell to about 7% of days at 11 months, well below the roughly one-third of days reported in the first year of genital HSV-2. In other words, GHSV-1 can be passed to a partner, especially in the first months, but the risk drops over the first year.

Despite this milder profile, a GHSV-1 diagnosis can be emotionally devastating — in part because many people do not realize that cold sores can be transmitted to the genitals, and in part because the word "genital" in the diagnosis triggers all the stigma associated with sexually transmitted infections. Medically, genital HSV-1 usually follows a milder course than genital HSV-2. For more on what this specific diagnosis means, see our deep dive into GHSV-1.

If you have been diagnosed with GHSV-1, it is important to arm yourself with facts. This will not only help you manage your own emotional response but will also equip you to have informed conversations with current and future partners.

How Common Is Herpes? The Real Statistics

Herpes is, by a substantial margin, one of the most common infections on the planet. According to the World Health Organization's 2020 estimates, about 3.8 billion people under the age of 50 — 64% of people in that age group worldwide — have HSV-1, and about 520 million people aged 15 to 49 (13%) have HSV-2. Most HSV-1 infections are acquired in childhood. Taken together, these numbers mean that most people under 50 carry at least one type of herpes simplex virus.

In the United States, national blood-test survey data from 2015–2016 found HSV-1 in 47.8% and HSV-2 in 11.9% — about one in eight — of people aged 14 to 49, according to the CDC's National Center for Health Statistics. Because these estimates come from testing blood samples rather than from diagnoses, they include the many people who do not know they carry the virus. They cannot show how many HSV-1 infections are genital, though, because an HSV-1 blood test cannot tell whether the infection is oral or genital.

These statistics matter because they dismantle the narrative that herpes is rare or that having it makes you fundamentally different from the people around you. The truth is that herpes is a majority experience — especially HSV-1. The reason it feels rare is because most people do not talk about it, many do not know they have it, and few are tested for it. In the United States, CDC guidelines do not recommend HSV-2 blood-test screening for the general population, so many people without symptoms are never tested for herpes. For a deeper statistical breakdown, see our article on herpes statistics.

When you understand how common herpes is, the stigma begins to crumble. You are not an outlier. You are not damaged. You are part of a global majority that simply does not talk about it openly — yet.

How Is Herpes Transmitted?

Herpes is transmitted through direct skin-to-skin contact with an area of the body that is shedding the virus. This can occur during vaginal sex, anal sex, oral sex, kissing, or any intimate contact that involves the affected area. According to the CDC, you will not get genital herpes from toilet seats, bedding or swimming pools, or from touching objects such as silverware, soap or towels. Oral herpes is slightly different: the WHO advises people with cold sore symptoms not to share items that have touched saliva.

Transmission risk varies based on several factors: the type of herpes, the direction of transmission (the WHO notes that HSV-2 passes more efficiently from men to women, so women acquire it almost twice as often), whether the positive partner is on antiviral medication, whether condoms are used, and whether an active outbreak is present. During an outbreak, the risk of transmission is highest, which is why avoiding sexual contact while symptoms are present is one of the most important precautions.

Condoms lower the risk but do not remove it, because herpes can spread from skin that a condom does not cover. In a pooled analysis of six prospective studies, people who used condoms every time had a 30% lower risk of acquiring HSV-2 than people who never used them, and the risk rose with each unprotected sex act.

Herpes can also be transmitted when no symptoms are present. This is called asymptomatic shedding, and CDC treatment guidelines note that most genital herpes infections are passed on by people who do not know they have the infection or who have no symptoms at the time. Asymptomatic shedding is unpredictable — there is no way to know when it is happening without laboratory testing. This is why condoms and, for many people, daily antivirals matter even between outbreaks. Talk to your healthcare provider about which options suit you. For specific numbers and risk-reduction strategies, our article on herpes transmission rates breaks down the science in detail.

Understanding transmission is empowering. When you know the actual risks and the tools available to reduce them, herpes goes from being a source of fear to a manageable variable in your intimate life.

Viral Shedding: Transmission Without Symptoms

Viral shedding is the process by which herpes simplex virus travels from the nerve ganglia where it resides to the surface of the skin, where it can potentially be transmitted to another person. Shedding can occur with or without visible symptoms. When it occurs without symptoms, it is called asymptomatic shedding, and it is one of the most misunderstood aspects of herpes.

As noted above, shedding without symptoms is a major route of transmission, simply because people who do not know they are shedding do not know to take precautions. The frequency of shedding varies between individuals and between virus types. Genital HSV-2 sheds much more often than genital HSV-1, and shedding tends to be most frequent in the first year after infection.

Daily suppressive antiviral therapy, most commonly valacyclovir (Valtrex), reduces shedding substantially. In a shedding substudy of the largest trial in couples, the virus was found in genital samples on 2.9% of days among people taking daily valacyclovir, compared with 10.8% of days among people taking a placebo — a reduction of roughly 70%. This is in addition to the clinical benefit of fewer and milder outbreaks. For people in serodiscordant relationships or those who are sexually active, daily antivirals are one of the most effective tools for reducing transmission risk; your healthcare provider can tell you whether they are right for you. For a more detailed explanation, read our piece on herpes shedding explained.

While the concept of asymptomatic shedding can initially feel alarming, understanding it actually puts you in a position of strength. You know the risk exists, and you know the tools available to manage it. That is far more than most people — including many who unknowingly carry herpes — can say.

Herpes Testing: IgG, PCR, and Western Blot

Herpes testing is more nuanced than testing for most other infections, and understanding the different test types is crucial for interpreting your results accurately. The three main testing methods for herpes are the IgG blood test, the PCR swab test, and the Western Blot. Each has its strengths and limitations, and the appropriate test depends on your specific situation.

The IgG blood test detects antibodies your immune system produces in response to herpes infection. Type-specific IgG tests can distinguish between HSV-1 and HSV-2 and do not require an active outbreak. However, they have notable limitations. False-negative results are more likely early after infection, so CDC guidelines advise repeating the test 12 weeks after a suspected exposure. And the most widely used HSV-2 antibody test (HerpeSelect) is often falsely positive at low index values (1.1–3.0), so the CDC advises confirming a low-positive result with a second, different test, such as the Biokit test or a Western blot, before acting on it.

The PCR swab test (a type of nucleic acid amplification test, or NAAT) is performed directly on a sore or suspected lesion and detects viral DNA. CDC guidelines describe NAAT as the most sensitive test for herpes sores, but it needs an active sore to swab. The Western blot is a specialized antibody blood test that the CDC lists as a confirmatory option when standard IgG results are uncertain; because it is specialized, ask your provider whether and how it can be ordered. Finally, CDC guidelines do not recommend HSV-2 blood-test screening for the general population, so ask your provider whether testing makes sense for you. For a comprehensive breakdown of all testing options, see our guide to herpes testing and our article on false positive herpes tests.

If you are navigating the testing process, the most important takeaway is this: not all positive results are truly positive, and a single test type does not always tell the whole story. Advocate for yourself, ask questions, and seek confirmatory testing when results are unclear.

Can Herpes Be Cured? Treatments and Antivirals

As of 2026, there is no cure for herpes simplex virus. Once the virus establishes latency in the nerve ganglia, it cannot be fully eliminated from the body with current medical technology. However, this does not mean herpes is untreatable. Antiviral medications are highly effective at managing the virus, and ongoing research continues to explore potential cures and therapeutic vaccines.

The most commonly prescribed antivirals for herpes are acyclovir, valacyclovir (the prodrug of acyclovir, sold as Valtrex), and famciclovir. These medications work by interfering with the virus's ability to replicate. They can be taken episodically — at the onset of an outbreak to shorten its duration and severity, ideally within 48 hours of symptoms starting, according to the WHO — or daily as suppressive therapy to reduce outbreak frequency and lower the risk of transmission to partners.

According to CDC treatment guidelines, daily suppressive therapy reduces how often outbreaks happen by 70% to 80% in people who have frequent outbreaks. In the largest trial in couples (1,484 heterosexual couples, all counseled on safer sex and offered condoms), daily valacyclovir cut new HSV-2 infections in partners roughly in half: 1.9% of partners acquired HSV-2 over eight months, compared with 3.6% in the placebo group, and symptomatic infections fell by about 75%. The CDC also notes that long-term safety and efficacy have been documented for daily acyclovir, valacyclovir and famciclovir. Your healthcare provider can help you choose between episodic and daily treatment and pick the right medicine and dose. For a more detailed look at treatment options, see our antivirals guide.

While a cure remains the ultimate goal, the treatments available today work well. For many people, antivirals make outbreaks rarer, shorter and milder. Research toward better prevention and treatment is also under way; the WHO, for example, is supporting work on herpes vaccines and topical microbicides. For ongoing coverage of that research and the policy work pushing it forward, the patient-led nonprofit Herpes Cure Advocacy publishes regular research and advocacy updates and is one of the best independent sources for tracking progress toward a cure.

Herpes Symptoms vs Other Conditions

Herpes symptoms can vary dramatically from person to person. Some individuals experience classic outbreaks with clearly visible blisters, while others have symptoms so mild they are easily mistaken for other conditions — razor burn, ingrown hairs, yeast infections, jock itch, or contact dermatitis. In fact, the WHO notes that most herpes infections cause no symptoms or go unrecognized.

A classic herpes outbreak often begins with a prodromal phase — a tingling, itching, or burning sensation in the area where sores will appear. This is followed by small blisters that break open, ooze, and then crust over as they heal; the CDC notes the sores may take a week or more to heal. First outbreaks tend to be the most severe and may be accompanied by fever, body aches, headache, and swollen lymph nodes.

Subsequent outbreaks are usually shorter and less severe. Many people notice a pattern to their outbreaks — the WHO lists triggers including illness or fever, sun exposure, menstrual periods, injury, emotional stress, and surgery. Identifying your personal triggers can help you anticipate and manage outbreaks more effectively. For help distinguishing herpes from look-alike conditions, see our article on herpes symptoms vs other conditions.

If you suspect you have herpes but are unsure, the best course of action is to see a healthcare provider while sores are present for a swab test. Visual diagnosis alone is not reliable — many conditions can mimic herpes, and CDC guidelines advise confirming a suspected genital herpes diagnosis with a type-specific laboratory test of the sore.

Herpes and Pregnancy: What to Know

One of the most common concerns for people diagnosed with herpes — particularly women — is how the virus will affect pregnancy and childbirth. The good news is that most women with herpes have healthy pregnancies and deliver healthy babies. Neonatal herpes is rare — the WHO estimates about 10 cases per 100,000 births worldwide — although it is serious when it happens, which is why it is worth planning for.

The primary risk to a newborn occurs when the mother acquires herpes for the first time late in pregnancy. CDC treatment guidelines put the risk of passing the virus to the baby at 30% to 50% when genital herpes is acquired near the time of delivery, because the mother has not yet developed antibodies that help protect the baby. That is why preventing a new infection in late pregnancy matters so much.

For women who already had recurrent herpes before pregnancy, the CDC puts the risk to the baby at less than 1%. Daily suppressive antiviral treatment starting at 36 weeks of pregnancy reduces the need for a cesarean delivery in women with recurrent genital herpes, and women who have herpes sores at the onset of labor should have a cesarean delivery to lower the risk to the baby. Your OB-GYN can tell you which plan fits your situation. For a comprehensive discussion of this topic, see our article on herpes and pregnancy.

Herpes should not deter you from starting a family if that is what you want. Tell your OB-GYN that you have herpes early in pregnancy; open communication and a clear plan for the final weeks are the main tools for managing the risk. For a broader understanding of the dating and relationship side of living with HSV, see our complete guide to dating with herpes.